2010 Annual Scientific Meeting and Exposition 2010 Annual ...

Tuesday Morning May 48:45 AM LB-OR-06: Incremental Predictive Value ofNoninvasive Vascular Assessments Over TraditionalRisk Factors in Patients with Hypertension, Diabetesand Renal DiseaseOana Sandu, 1 Iulian Natac, 2 Jaime Uribarri. 1 1 MSSM,NY, NY, US and 2 PUB, Bucharest, RO.8:57 AM LB-OR-07: Baseline Levels of Systolic BloodPressure and LDL-C Are Powerful Predictors ofCardiovascular Outcomes Among 12,839 Patients atHigh Risk of Future EventsPrakash Deedwania†, 1 Helen Colhoun. 2 1 VACCHCS/UCSF School of Medicine, Fresno, US and 2 Universityof Dundee, Dundee, GB.9:09 AM LB-OR-08: Rheos® Baroreflex Activation Therapy®Significantly Lowers Blood Pressures in Patientswith Resistant Hypertension: Results from PivotalTrial Roll-In SubjectsGeorge L. Bakris†, 1 John Bisognano, 2 Mitra Nadim, 3Luis Sanchez, 4 Domenic A. Sica. 5 1 University ofChicago, US; 2 University of Rochester School ofMedicine, US; 3 University of Southern CaliforniaKeck School of Medicine, US; 4 Washington UniversitySchool of Medicine, US and 5 Virginia CommonwealthUniversity, US.9:21 AM LB-OR-09: Effects of Intensive Blood PressureControl on Stroke and Other Cardiovascular Eventsin Type 2 Diabetes Mellitus: The Action to ControlCardiovascular Risk in Diabetes (ACCORD) BloodPressure TrialWilliam C. Cushman, 1 Gregory W. Evans, 2 Jeffrey A.Cutler, 3 Richard H. Grimm, Jr., 4 For the ACCORDStudy Group. 1 Preventive Medicine Section, MemphisVeterans Affairs (VA) Medical Center, Memphis,TN, US; 2 Division of Public Health Sciences, WakeForest University School of Medicine, Winston-Salem,NC, US; 3 National Heart, Lung, and Blood Institute,Bethesda, MD, US and 4 Berman Center for Outcomesand Clinical Research, Minneapolis, MN, US.95